![]() |
市場調查報告書
商品編碼
1847206
歐洲的牙科用植入市場:市場規模,佔有率,趨勢分析(2025年~2031年)Dental Implants Market Size, Share & Trends Analysis | Europe | 2025-2031 | Includes: Dental Implants, Final Abutments, Instrument Kits, and 2 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024年,歐洲牙科植體和最終基台市場規模超過13億歐元,預計到2031年將達到近19億歐元,預測期內複合年增長率(CAGR)為4.8%。
本報告涵蓋牙科植體、最終基台、治療計畫軟體和手術導板。牙科植體按高端、經濟型、折扣型和迷你型進行細分,並按材料分為鈦和陶瓷/氧化鋯。最終基台按製造方式(現貨、客製化鑄造、CAD/CAM)和材料(鈦、陶瓷/氧化鋯、黃金)進行細分。治療計劃軟體分析包括新安裝費用和服務/維護費用,手術導板按製造商(傳統製造商、第三方製造商、內部製造商)進行細分。
本報告量化了單位銷售、平均售價 (ASP)、市場價值、成長率和公司佔有率。報告還評估了市場推動因素和阻礙因素、技術和工作流程趨勢以及近期併購活動。歷史資料截至 2021 年,預測資料截至 2031 年。報告的結構和流程與 iData 的輸液治療設備參考手冊格式一致,確保經銷商頁面的一致性。
市場概覽
歐洲植體和基台市場正穩步從傳統的類比工作流程向數位化牙科轉型,將診斷、計劃、植入和修復環節連接起來。基於 CBCT 的計劃、導板手術和 CAD/CAM 基台的應用提高了治療精度並縮短了就診時間。這增強了新晉臨床醫生的信心,並提高了全科診所對此類病例的接受度。
由於患者尋求美觀耐用且能與天然牙齒融合的解決方案,單顆牙齒修復的需求增長速度超過了義齒固位的需求。高端種植系統憑藉其悠久的臨床歷史、全面的組件庫和強大的服務網絡,在複雜且注重美觀的病例中保持優勢。同時,經濟型和折扣型品牌正在常規適應症、聯合診所和價格敏感型市場中佔越來越大的佔有率,這給多個國家的平均銷售價格(ASP)帶來了下行壓力。
隨著技工室和椅旁系統簡化掃描提交和設計審核流程,最終基台領域正朝著CAD/CAM方向發展。開放式架構的工作流程允許來自不同掃描器和設計工具的數位檔案導入相容的加工系統,從而擴大了CAD/CAM基台的應用範圍。這一趨勢提高了靈活性,減少了返工,並確保了品質的一致性。
治療計畫軟體部門從定期維護和續訂費用中獲利。隨著安裝量的成長,龐大的用戶群支撐著穩定的服務收入。隨著診所和實驗室數位化能力的提升,手術導板正逐漸從診所內部製造商轉向第三方製造商,但對於複雜的多單元和全口種植病例,製造商生產的導板仍然是主流選擇。
義大利、瑞士、斯堪的納維亞半島和比荷盧經濟聯盟的植牙普及率已經很高。法國和英國的植牙普及率較低,但仍有成長空間,而宣傳活動、融資方案和數位化工作流程正在推動植牙的普及。宏觀經濟因素和家庭信心將繼續影響病例組合和治療時機,尤其是在選擇性美學治療方面。
市場推動因素
對較佳美觀效果的需求
歐洲患者仍偏好牙色、外觀自然的修復體,這些修復體既能保持功能,又能維護長期的口腔健康。與牙橋相比,植牙的優點在於無需磨除鄰牙,並能保留齒槽骨。因此,單顆植牙修復體是成長最快的細分市場。即使在整體經濟狀況疲軟的情況下,病患教育、大眾對植牙的接受度以及診所的融資方案也能確保病例數的穩定。
數位化牙科
數位化工具的快速成熟正在推動植牙置換率的提高。錐狀束CT (CBCT) 可以精確地以三維形式呈現骨量和解剖結構,從而改善治療計劃和風險評估。導板手術軟體可以將這些治療計劃轉化為精確的手術導板。 CAD/CAM 解決方案可以創建患者客製化的基台,從而優化牙齦輪廓和軟組織支撐。製造商正在投資教育中心和區域創新中心,以擴大數位化應用並縮短學習曲線。這些投資提高了護理標準,提高了病例接受度,並將客戶鎖定在整合的軟硬體生態系統中。
改進的兼容性和開放的工作流程
供應商正在開放其系統,以接受來自更多設備和平台的掃描和 CAD 檔案。例如,植體規劃套件與主流口內掃描器的兼容性,使臨床醫生無需改造現有設備即可提交病例。開放式架構減少了摩擦,擴大了CAD/CAM基台的取得途徑,並支援互補產品的交叉推廣。這使得庫存和客製化基台的訂單流程更加順暢,並增強了相關植體、器械和修復組件的銷售。
市場限制因子
可支配所得與消費者信心
植牙通常是一種選擇性消費。當消費者信心下降時,患者會延後單顆牙齒修復或選擇成本較低的替代方案。這種趨勢因國家而異,自付費用和私人保險會影響需求。雖然診所正在透過分階段治療計劃和融資來應對,但宏觀經濟壓力仍可能推遲高端產品組合和全口種植病例的出現。
經濟型和折扣型植體的日益普及
經濟型和折扣型品牌憑藉可靠的核心性能和更低的價格,持續擴大市場佔有率。這種轉變壓縮了品類層面的平均售價。為了保持競爭力,即使是高端品牌也在透過選擇性折扣、產品組合捆綁和教育項目來捍衛其市場佔有率。在常規適應症和價格敏感型市場,這種壓力最為顯著,因為高端產品和經濟型產品之間的認知差距正在縮小。
成熟國家的高市場滲透率
成熟的植體市場已經擁有很高的滲透率。進一步成長取決於從競爭對手手中奪取市場佔有率、將適應症擴展到更年輕的人群以及將傳統診所升級為數位化工作流程。法國和英國等植體滲透率歷來較低的國家正在提供更多治療選擇,但成長仍取決於臨床醫生的培訓、患者的融資以及能夠降低風險的可預測治療結果。
對象市場與資料範圍
定量的範圍
市場規模,市場佔有率,市場預測,成長率,銷售台數,平均銷售價格。
定性的範圍
成長趨勢,阻礙因素,競爭分析及競爭前幾名企業的SWOT,M&A,企業簡介及產品系列,FDA回收,顛覆性技術,輸液療法的需求形成的疾病概要。
期間
基準年(2024年),預測(2025年~2031年),過去資料(2021年~2023年)
資料來源
對產業領導者的1次採訪,政府醫生資料,法規資料,醫院私人資料,進出口資料,iData Research公司內部資料庫。
市場區隔
人工植牙
最終基台
器械包
治療計劃軟體
分析中,包含新安裝,更新,支援,整合相關的服務/維修費。
手術模板
競爭分析
士卓曼集團將在2024年佔歐洲市場最大的市場佔有率。其領先地位源於其在植牙和最終基台領域的強大實力,以及在治療計劃軟體和手術導板領域的顯著影響力。本公司提供涵蓋鈦基和陶瓷植體的各種價格區間的產品,包括高端、經濟型(包括Neodent)和折扣產品。士卓曼的產品組合涵蓋全口修復、CAD/CAM基台和再生生物材料,增強了客戶黏性。持續投資於數位化工作流程和教育,使其保持了先發優勢。
登士柏西諾德憑藉其在治療計劃軟體和手術導板領域的領先地位以及豐富的植體產品組合,在市場佔有率方面位居第二。其SIMPLANT®和SICAT®軟體的深度積累,使其在計劃、資料管理和導板製造方面擁有強大的實力。 CAD/CAM解決方案以及與第三方掃描器不斷擴展的兼容性,支援高效的修復工作流程,從而推動了對基台和植體的需求。
Envista透過其子公司Nobel Biocare和Implant Direct位居第三。 Nobel Biocare是All-on-4®數位化工作流程的先驅,也是一家主要的高端企業,提供整合植體、基台和相關組件的綜合系統。 Envista透過覆蓋高端和經濟型市場,吸引了廣泛的客戶群。
持續的技術創新推動持續成長。
其他進入者服務全國性和細分市場。本地領導者在價值和折扣市場競爭,通常利用強大的經銷商關係和有吸引力的定價策略。專注於高端市場的中型企業利用陶瓷植體和先進的基台材料,滿足美觀和複雜的適應症需求。
技術與實務趨勢
端到端的數位化工作流程結合了錐形束CT (CBCT)、口內掃描、規劃軟體、導板手術和CAD/CAM基台,以提高精度並縮短椅旁操作時間。
開放式架構相容性。更廣泛的文件接受度和掃描器互通性簡化了病例提交,減少了返工,並支持CAD/CAM基台的穩定成長。
陶瓷/氧化鋯的擴張。由於美觀且不含金屬,陶瓷植體和氧化鋯基台在前牙區越來越受歡迎,但鈦仍然是大多數適應症的標準選擇。
全口和即刻修復方案。標準化組件和規劃工具支援符合骨質和穩定性標準的全口治療和即時負重。
教育和中心。供應商正在投資培訓中心和數位化實驗室,以縮短學習曲線並促進一致的臨床結果。
分散式導板製造。隨著實驗室和診所開發列印和驗證能力,內部和第三方導板製造將會擴大,而製造商將在複雜病例中保持市場佔有率。
區域
本期重點在於歐盟 (EU)。
包含方法附錄和縮寫。
到 2031 年,歐洲植體、基台、軟體和導板領域中規模最大、成長最快的機會在哪裡?
價值型和折扣型產品的市佔率成長速度及其對平均售價和產品組合的影響。
哪些數位化工具對日常診療中的個案接受率、準確率和返工率影響最大?
開放式工作流程和掃描器相容性將如何影響 CAD/CAM 基台的需求和技工室的運作?
美學區陶瓷/氧化鋯植體和基台的前景如何?
宏觀經濟的不確定性將如何影響擇期治療的時機、病患的融資、全口種植個案的規劃?
iData Research 的 "歐洲牙科植體和最終基台市場報告" 透過基於流程的模型、公司佔有率分析和定價詳情,解答了這些問題。
利用該報告量化需求、確定產品路線圖的優先順序、協調培訓和教育,並優化歐洲高端、價值和折扣細分市場的商業策略。
圖表一覽
表(圖表)一覽
歐洲的人工植牙及最終基台市場概要
競爭分析
市場趨勢
市場趨勢
終端用戶分析
市場區隔
主要的報告的更新
版本履歷
調查手法
全球關稅的影響
歐洲的人工植牙及最終基台市場概要
國家概況
終端用戶分析
人工植牙市場
最終基台市場
治療計劃軟體市場
手術指南市場
The European market for dental implants and final abutments was valued at over €1.3 billion in 2024. The market is expected to increase at a CAGR of 4.8% over the forecast period to reach nearly €1.9 billion by 2031.
This report covers dental implants, final abutments, treatment planning software, and surgical guides. Dental implants are segmented into premium, value, discount, and mini categories and also by material as titanium and ceramic/zirconia. Final abutments are segmented by fabrication (stock, custom cast, CAD/CAM) and by material (titanium, ceramic/zirconia, gold). Treatment planning software analysis includes new installations and service/maintenance fees, while surgical guides are segmented by manufacturing source (traditional manufacturer, third party, in-house).
The report quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares. It evaluates market drivers and limiters, technology and workflow trends, and recent mergers and acquisitions. Historical data are provided to 2021 with forecasts through 2031. The structure and flow mirror the format used in iData's infusion therapy device reference to aid consistency across reseller pages.
Market Overview
Europe's implant and abutment market reflects a steady shift from traditional analog workflows to digital dentistry that links diagnostics, planning, placement, and restoration. Adoption of CBCT-based planning, guided surgery, and CAD/CAM abutments is improving treatment accuracy and shortening chair time. This is increasing confidence among newer clinicians and raising case acceptance rates in general practice settings.
Demand for single-tooth replacement is expanding faster than denture retention, as patients seek aesthetic and durable solutions that integrate with natural dentition. Premium implant systems maintain an edge in complex and esthetic cases due to long clinical histories, comprehensive component libraries, and robust service networks. At the same time, value and discount brands are winning share in routine indications, group practices, and price-sensitive markets, which places downward pressure on ASPs in several countries.
The final abutment segment is moving toward CAD/CAM as labs and chairside systems streamline scan submission and design approvals. Open-architecture workflows are widening access to CAD/CAM abutments by allowing digital files from different scanners and design tools to flow into compatible production systems. This trend improves flexibility, reduces remakes, and supports consistent quality.
The treatment planning software segment benefits from recurring maintenance and update fees. As installations grow, the installed base supports stable service revenue. Surgical guides are shifting toward in-house and third-party fabrication as clinics and labs build digital capacity, though manufacturer-produced guides remain prevalent for complex multi-unit and full-arch cases.
Overall, unit growth is positive across Europe, with penetration already high in Italy, Switzerland, Scandinavia, and the Benelux region. Growth headroom remains in France and the U.K., where implant penetration is lower and awareness campaigns, financing options, and digital workflows can lift adoption. Macroeconomic factors and household confidence still influence case mix and timing, particularly for elective esthetic treatments.
Market Drivers
Demand for Improved Aesthetics
European patients continue to prefer tooth-colored, natural-looking restorations that preserve function and support long-term oral health. Implants offer advantages over bridges by avoiding preparation of adjacent teeth and by preserving bone. As a result, single-tooth replacement is the fastest growing application. Wider patient education, social acceptance of implants, and financing options from clinics support steady case volumes even when general economic sentiment softens.
Digital Dentistry
The rapid maturation of digital tools is raising the implant replacement rate. CBCT enables accurate 3D visualization of bone volume and anatomy, which improves treatment planning and risk assessment. Guided surgery software converts these plans into precise surgical guides. CAD/CAM solutions produce patient-specific abutments that optimize emergence profile and soft tissue support. Manufacturers are investing in education hubs and regional innovation centers to expand digital adoption and shorten learning curves. These investments raise the standard of care, support higher case acceptance, and anchor customers within integrated software-hardware ecosystems.
Increased Compatibility and Open Workflows
Vendors are opening their systems to accept scans and CAD files from a broader set of devices and platforms. For example, compatibility between implant planning suites and leading intraoral scanners allows clinicians to submit cases without changing existing equipment. Open architecture reduces friction, expands access to CAD/CAM abutments, and supports cross-promotion of complementary products. The result is a smoother order flow for stock and custom abutments and stronger pull-through for associated implants, instruments, and restorative components.
Market Limiters
Disposable Income and Consumer Confidence
Implant dentistry is often an elective purchase. When consumer confidence weakens, patients may delay single-tooth replacement or choose lower-cost alternatives. This dynamic varies by country, with out-of-pocket exposure and private insurance coverage shaping demand. Clinics respond with staged treatment plans and financing, but macroeconomic pressure can still slow premium mix and full-arch cases.
Growing Popularity of Value and Discount Implants
Value and discount brands continue to gain share by offering reliable core performance at lower prices. This shift compresses ASPs at the category level. To stay competitive, even premium brands use selective discounting, portfolio bundling, and education programs to defend share. Pressure is strongest in routine indications and price-sensitive markets where the perceived gap between premium and value outcomes is narrower.
High Market Penetration in Mature Countries
In long-established implant markets, penetration is already high. Incremental growth depends on winning share from competitors, expanding indications to younger cohorts, and upgrading analog clinics to digital workflows. Countries with lower historical penetration, such as France and the U.K., offer more runway, but growth still relies on clinician training, patient financing, and predictable outcomes that reduce perceived risk.
Market Coverage and Data Scope
Quantitative coverage
Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage
Growth trends, limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls, disruptive technologies, and disease overviews that shape demand for infusion therapy.
Time frame
Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.
Data sources
Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import and export data, and the iData Research internal database.
Market Segmentation
Dental Implants
Final Abutments
Instrument Kit
Treatment Planning Software
Analysis includes new installations and service/maintenance fees tied to updates, support, and integration.
Surgical Guides
Competitive Analysis
Straumann Group held the largest share of the total European market in 2024. Leadership stems from strong positions in dental implants and final abutments, with meaningful presence in treatment planning software and surgical guides. The company addresses all price tiers through premium, value (including Neodent), and discount offerings, and spans titanium and ceramic implants. Straumann's portfolio integrates full-arch restorations, CAD/CAM abutments, and regenerative biomaterials, which strengthens account stickiness. Continuous investment in digital workflows and education sustains its first-mover advantage.
Dentsply Sirona held the second-largest share, driven by leadership in treatment planning software and surgical guides and by a broad implant portfolio. The company's software heritage through SIMPLANT(R) and SICAT(R) underpins strong positions in planning, data management, and guide production. Its CAD/CAM solutions and expanding compatibility with third-party scanners support efficient restorative workflows and help pull through abutment and implant demand.
Envista ranked third through its subsidiaries Nobel Biocare and Implant Direct. Nobel Biocare pioneered the All-on-4(R) digital workflow and remains a key premium player with comprehensive systems that include implants, abutments, and related components in integrated packages. Envista's coverage of premium and value tiers supports broad customer reach, while continued innovation under Nobel Biocare positions the group for ongoing growth.
Other participants serve national and niche segments. Local champions compete in value and discount tiers, often with strong distributor relationships and attractive price points. Premium-focused midsize firms address esthetic and complex indications with ceramic implants and advanced abutment materials.
Technology and Practice Trends
End-to-end digital workflow. Clinics combine CBCT, intraoral scanning, planning software, guided surgery, and CAD/CAM abutments to improve accuracy and cut chair time.
Open architecture compatibility. Broader file acceptance and scanner interoperability simplify case submission and reduce remakes, supporting steady CAD/CAM abutment growth.
Ceramic/zirconia expansion. Ceramic implants and zirconia abutments gain attention for esthetics in the anterior zone and for metal-free preferences, though titanium remains the standard for most indications.
Full-arch and immediate protocols. Standardized components and planning tools support full-arch treatments and immediate loading where bone quality and stability criteria are met.
Education and hubs. Vendors invest in training centers and digital labs to shorten learning curves and promote consistent clinical outcomes.
Distributed guide manufacturing. In-house and third-party guide production expands as labs and clinics develop printing and validation capabilities, while manufacturers retain share in complex cases.
Geography
This edition covers the European Union.
Methodology Appendix and Acronym Glossary included.
Where are the largest and fastest-growing opportunities within Europe's implant, abutment, software, and guide categories through 2031.
How fast are value and discount segments gaining share and what are the implications for ASPs and mix.
Which digital tools most influence case acceptance, accuracy, and rework rates in daily practice.
How do open workflows and scanner compatibility shape CAD/CAM abutment demand and lab operations.
What is the outlook for ceramic/zirconia implants and abutments in esthetic zones.
How does macroeconomic uncertainty affect elective treatment timing, patient financing, and full-arch case pipelines.
The European Dental Implant and Final Abutment Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail.
Use it to quantify demand, prioritize product roadmaps, align training and education, and optimize commercial strategies for premium, value, and discount segments across Europe.
Table Of Contents
List Of Figures
List Of Charts
European Dental Implant And Final Abutment Market Overview
Competitive Analysis
Market Developments
Market Trends
End-User Analysis
Market Segmentation
Key Report Updates
Version History
Research Methodology
Impact Of Global Tariffs
European Dental Implant And Final Abutment Market Overview
Country Profiles
End-User Analysis
Dental Implant Market
Final Abutment Market
Treatment Planning Software Market
Surgical Guide Market